title: Ivory wave: the next mephedrone?
abstract: BACKGROUND
  Since the classification of miaow miaow (mephedrone) as a class B drug in April this year, a new drug is emerging as a so-called 'legal high'. Deaths have already been attributed to ivory wave in different parts of the country.
  
  
  METHODS
  A case study is presented, and relevant literature is explored in order to better understand the drug and its effects in the human body.
  
  
  RESULTS
  Overstimulation of the nervous system can cause acute paranoid psychosis, dizziness, hyperthermia and potential fitting. Effects on the cardiovascular system include tachycardia, chest pains, S-T segment changes, and blood pressure variations with potential renal implications.
  
  
  CONCLUSIONS
  Ivory wave's popularity seems to be growing and it seems quite plausible that this drug could become 'the next mephedrone'. Clinicians should be aware of its likely presentations, dangers, and management.
authors.affiliation: Brighton Ambulance Station, Elm Grove, Brighton BN2 3EU, UK. mark.durham@secamb.nhs.uk
authors.forename: Mark
authors.initials: M
authors.lastname: Durham
mesh_terms: D052117:Benzodioxoles / Q000009:adverse effects*; D002637:Chest Pain / Q000139:chemically induced*; D004338:Drug Combinations; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects*; D008012:Lidocaine / Q000009:adverse effects*; D008694:Methamphetamine / Q000009:adverse effects / Q000031:analogs & derivatives; D011759:Pyrrolidines / Q000009:adverse effects*; D006113:United Kingdom
chemical_list: D052117:Benzodioxoles; D004338:Drug Combinations; D013287:Illicit Drugs; D011759:Pyrrolidines; C569564:ivory wave; D008694:Methamphetamine; C548233:mephedrone; D008012:Lidocaine; C005719:pyrovalerone